Stocktoria
Quanterix Corp QTRX
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2017-12-07
Quanterix Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $138.9M | $137.4M | $122.4M | $105.5M | $110.6M |
| Gross profit | $65.0M | $83.1M | $74.2M | $45.4M | $61.7M |
| R&D expense | $35.9M | $31.1M | $26.1M | $26.8M | $28.0M |
| SG&A expense | $138.0M | $101.6M | $89.1M | $91.9M | $92.3M |
| Operating income | -$125.5M | -$52.6M | -$46.0M | -$104.3M | -$58.6M |
| Income tax | -$5.1M | $434,000 | $719,000 | $164,000 | -$36,000 |
| Net income | -$107.2M | -$38.5M | -$28.4M | -$99.6M | -$57.7M |
| EPS (diluted) | $-2.51 | $-1.00 | $-0.75 | $-2.69 | $-1.60 |
| Operating cash flow | -$77.2M | -$35.2M | -$18.8M | -$48.6M | -$47.9M |
| Free cash flow | -$79.8M | -$38.5M | -$22.7M | -$60.2M | -$61.5M |
| Cash & equivalents | $29.8M | $56.7M | $174.4M | $338.7M | $396.5M |
| Inventory | $54.8M | $32.8M | $26.1M | $16.8M | $22.2M |
| Total assets | $418.8M | $406.5M | $428.6M | $434.2M | $501.5M |
| Total liabilities | $123.0M | $76.5M | $78.6M | $75.3M | $60.6M |
| Shareholders' equity | $295.7M | $330.0M | $350.0M | $357.9M | $442.8M |
Source: SEC EDGAR filings · CIK 0001503274 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.